A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
$1,498,045N44FY2022AINIH
Intralytix, Inc., Baltimore MD
Investigators
Abstract
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications.
View original record on NIH RePORTER →